If you need more lookups,
subscriptions start at $34 USD/month.
Anna Berglind Location
Denmark
Anna Berglind Work
Vice President Biometrics, Rare Disease and Advanced Therapies @ (November 2024 - Present)
Vice President Biostatistics, Rare Disease and Advanced Therapies @ (May 2024 - November 2024)
Executive Director and Head of Immunology Statistics @ (May 2020 - May 2024)
Board Member @ (June 2016 - July 2020)
Director and Biometrics Team Leader @ (June 2013 - May 2020)
Associate Director @ (October 2005 - July 2011)
Statistical Science Director, Global Product Statistician @ (August 2011 - May 2013)
Senior statistician @ (January 2002 - January 2005)
Anna Berglind Education
Umeå universitet
Doctor of Philosophy (Ph.D.) (Mathematical Statistics)
1997-2002
Anna Berglind Skills
Biostatistics
SAS
Clinical Development
Neuroscience
Clinical Trials
Pharmaceutical Industry
Drug Development
CRO
Biomarkers
GCP
Infectious Diseases
Science
Statistics
Datawarehouse
Development
SAP
Sourcing
BigData
BI
Data
Business Objects
Webi
Business Intelligence
Datamining
Analytics
Biometrics
Anna Berglind Summary
Anna Berglind, based in Denmark, is currently a Vice President Biometrics, Rare Disease and Advanced Therapies at Novo Nordisk. Anna Berglind brings experience from previous roles at Novo Nordisk, AstraZeneca and Statisticians in the Pharmaceutical Industry Ltd (PSI). Anna Berglind holds a 1997 - 2002 Doctor of Philosophy (Ph.D.) in Mathematical Statistics @ Umeå universitet. With a robust skill set that includes Biostatistics, SAS, Clinical Development, Neuroscience, Clinical Trials and more. Anna Berglind has 1 emails on RocketReach.
Looking for a different Anna Berglind?
Find contact details for 700 million professionals.